Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-Iodine 1% for Anterior Blepharitis
NCT05160623Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Aug 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, single-blind trial of IVIEW-1502 in blepharitis, sponsored by Shaare Zedek Medical Center. Primary endpoint: Blepharitis signs on slit-lamp examination at 30 days. Status: unknown.
02
Drugs
IVIEW-1502
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT05160623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05160623.